HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

LC15-0444

Dipeptidyl Peptidase IV Inhibitors; orally active small molecule for the treatment of type II diabetes
Also Known As:
gemigliptin
Networked: 64 relevant articles (12 outcomes, 28 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Yu, Kyung-Sang: 7 articles (01/2021 - 10/2008)
2. Jang, In-Jin: 6 articles (01/2021 - 10/2008)
3. Kim, Sung-Ho: 6 articles (01/2017 - 12/2009)
4. Baik, Sei Hyun: 4 articles (01/2021 - 07/2014)
5. Lee, SeungHwan: 4 articles (01/2021 - 06/2014)
6. Cho, Joo-Youn: 4 articles (03/2020 - 10/2008)
7. Jung, Eunsoo: 4 articles (10/2016 - 12/2014)
8. Kim, Junghyun: 4 articles (10/2016 - 12/2014)
9. Lim, Kyoung Soo: 4 articles (01/2015 - 10/2008)
10. Min, Kyung Wan: 3 articles (01/2021 - 01/2018)

Related Diseases

1. Type 2 Diabetes Mellitus (MODY)
2. Insulin Resistance
3. Vascular Calcification
4. Metabolic Syndrome (Dysmetabolic Syndrome X)
5. Inflammation (Inflammations)

Related Drugs and Biologics

1. Dipeptidyl-Peptidase IV Inhibitors
2. Metformin (Glucophage)
3. Glucose (Dextrose)
4. dapagliflozin
5. Biomarkers (Surrogate Marker)
6. Solutions
7. AMP-Activated Protein Kinases
8. Fatty Acid-Binding Proteins
9. Retinaldehyde (Retinal)
10. Powders

Related Therapies and Procedures

1. Therapeutics
2. Glycemic Control
3. Ligation